Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine

Am J Psychiatry. 2008 Nov;165(11):1488-9. doi: 10.1176/appi.ajp.2008.07121972.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aggression / drug effects*
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Benztropine / administration & dosage
  • Benztropine / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Humans
  • Intellectual Disability / drug therapy*
  • Male
  • Neuroleptic Malignant Syndrome / etiology*
  • Neurologic Examination / drug effects
  • Olanzapine
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Quinolones / administration & dosage
  • Quinolones / adverse effects*
  • Risk Factors

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Benzodiazepines
  • Benztropine
  • Aripiprazole
  • Olanzapine